Floatz logo

ADVICOR COMPONENT NIACIN

Psilocybin

Yale UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Psilocybin cohort.

Asset / SponsorPhaseRating
TEONANACATL
University of California, Los Angeles
Phase 2CCC

Same molecule, other indications

ADVICOR COMPONENT NIACIN is also rated in:

inherited lipid metabolism disorderDormant
BBB
Indicative ·
73 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
73 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →